[Tamoxifen and breast cancer: is everything known already?].
作者信息
Marchetti P, Porzio G, Trapasso T, Baldi P L, Ficorella C
机构信息
Oncologia Medica, Dipartimento di Medicina Sperimentale, Università degli Studi, L'Aquila.
出版信息
Tumori. 1998 Nov-Dec;84(6):A1-5.
PMID:10080686
Abstract
摘要
相似文献
1
[Tamoxifen and breast cancer: is everything known already?].[他莫昔芬与乳腺癌：一切都已为人所知了吗？]
Tumori. 1998 Nov-Dec;84(6):A1-5.
2
Tamoxifen therapy--long-term results and complications.他莫昔芬治疗——长期结果与并发症
Adv Surg. 1996;29:263-9.
3
4
Status of antiestrogen breast cancer prevention trials.抗雌激素乳腺癌预防试验的现状。
Oncology (Williston Park). 1998 Mar;12(3 Suppl 5):28-31.
5
Gynaecological aspects of tamoxifen treatment in breast cancer patients.乳腺癌患者他莫昔芬治疗的妇科方面
Cancer Treat Rev. 1997 Sep-Nov;23(5-6):289-304. doi: 10.1016/s0305-7372(97)90029-3.
6
Tamoxifen in cancer therapy: minireview.他莫昔芬在癌症治疗中的应用：综述
Neoplasma. 2000;47(1):3-7.
7
Should tamoxifen users be screened for endometrial lesions?使用他莫昔芬的患者应该接受子宫内膜病变筛查吗？
Lancet. 1998 Jan 17;351(9097):155-7. doi: 10.1016/S0140-6736(05)78216-7.
8
One step forward or one step back with tamoxifen?他莫昔芬是前进还是后退一步？
Lancet. 2000 Sep 9;356(9233):868-9. doi: 10.1016/S0140-6736(00)02670-2.
9
The duration of adjuvant tamoxifen therapy.辅助性他莫昔芬治疗的持续时间。
Cancer Treat Res. 1998;94:181-93. doi: 10.1007/978-1-4615-6189-7_10.
10
Tamoxifen and the endometrium.他莫昔芬与子宫内膜
Cancer Treat Res. 1998;94:195-207. doi: 10.1007/978-1-4615-6189-7_11.
Zotero 插件